USDA Proposes Information Collection to Authorize Avian Influenza Vaccination in Zoos and Sanctuaries
In a notable expansion of federal biosecurity strategy, the United States Department of Agriculture has initiated a formal regulatory process to authorize the vaccination of captive wildlife against highly pathogenic avian influenza. Published in the Federal Register, the notice from the Animal and Plant Health Inspection Service details a proposed three-year information collection under the Paperwork Reduction Act of 1995. The initiative creates a collaborative mechanism between federal regulators and state animal health officials, establishing binding criteria for zoos, wildlife sanctuaries, and nonprofit animal care facilities seeking to protect susceptible species from a pathogen that has devastated avian populations nationwide.
Statutory Authority and Regulatory Context
The initiative draws its legal mandate from the Animal Health Protection Act, codified at 7 U.S.C. 8301 et seq. Under this statutory scheme, Congress granted the Secretary of Agriculture sweeping authority to prevent the introduction and interstate dissemination of severe livestock pests and contagious diseases, as well as to eradicate such threats whenever feasible. This broad police power over animal health has historically focused on agricultural production, commercial poultry operations, and international trade safeguards.
Highly pathogenic avian influenza represents an acute threat not only to commercial poultry producers but also to captive conservation populations and wild birds. Severe outbreaks carry profound economic consequences, disrupting interstate commerce and triggering international trade embargoes on domestic poultry exports. By extending controlled vaccine access to zoological institutions, federal regulators are opening a targeted pathway designed to preserve rare genetic stocks and high-value captive animals without undermining broader commercial disease surveillance protocols.
Standards for Facility Eligibility and Vaccination Plans
Participation in the newly proposed program is contingent on rigorous administrative and veterinary prerequisites. Facilities cannot simply purchase and administer vaccines independently. Instead, each institution must draft and submit a detailed Highly Pathogenic Avian Influenza Vaccination Plan directly to federal and state authorities for review.
The regulatory blueprint mandates direct clinical oversight by a Category II veterinarian accredited by the Department of Agriculture. In their formal submissions, facilities must provide an evidence-based justification for vaccination, map out inventory control systems, and specify biosecurity protocols designed to prevent cross-contamination. Crucially, the plan must guarantee the complete physical separation of vaccinated zoo animals from designated domestic poultry populations to prevent any confusion between wildlife preservation efforts and commercial poultry monitoring.
Additionally, participating institutions must maintain individual animal identification systems and comprehensive medical dossiers. The operational plan must outline strict procedures governing animal movements, transfers to other facilities, and post-mortem disposition. Regulators emphasized that noncompliance with these federal requirements will lead to the immediate suspension or formal revocation of facility authorization.
Surveillance Architecture and Manufacturer Obligations
The information collection notice establishes a closed-loop monitoring network involving licensed vaccine manufacturers, private wildlife facilities, and diagnostic laboratories. Once APHIS and state authorities approve an institution plan, the facility may procure licensed avian influenza vaccines directly from biological manufacturers.
To prevent gray-market diversion and maintain chain-of-custody integrity, vaccine manufacturers will be required to maintain detailed distribution and shipment logs. At the facility level, caretakers must document every dose administered and maintain rolling inventory audits. Furthermore, all participating entities must conduct mandatory diagnostic testing exclusively through laboratories that belong to the National Animal Health Laboratory Network.
This continuous laboratory surveillance ensures that health officials can monitor immune responses and confirm that vaccinated birds do not harbor subclinical infections. Participating facilities must file annual status updates and provide an exhaustive final summary report upon the conclusion of all vaccination activities.
Public Burden and Comment Period
In compliance with federal administrative procedural requirements, APHIS has submitted its reporting projections for public review and evaluation by the Office of Management and Budget. The agency estimates that approximately 160 respondents across the country will participate in the program annually. These respondents encompass zoo administrators, sanctuary directors, Category II accredited veterinarians, and vaccine manufacturers.
Federal analysts calculate an annual reporting frequency of six submissions per respondent, generating roughly 960 total annual responses. With an estimated burden of 1.043 hours per submission, the agency projects an aggregate annual administrative investment of 1,001 hours for the regulated community. Regulators are actively soliciting public input on whether the requested data collections are strictly necessary, whether the burden estimates are accurate, and how automated electronic systems might streamline compliance.
Members of the public, conservation groups, and agricultural industry representatives have until January 15, 2027, to submit formal comments through the federal eRulemaking portal or via standard mail to agency headquarters in Beltsville, Maryland. The submissions will form the evidentiary basis for the final request forwarded to the Office of Management and Budget for triennial clearance.
We are not a law firm. The information on this website is for informational purposes only and may not be up to date. Always consult a licensed attorney for personalized legal advice.